TotalMarketCap

Vogenx

VOGXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$243.475 M

$16.39 -4.43%

Close of 7 Oct 2026

As of 7 Oct 2026, Vogenx (VOGX) has a market capitalization of $243.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

14,855,087

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →
  1. #241Sol-Gel TechnologiesSLGL$247.6M
  2. #242Lifecore BiomedicalLFCR$244.2M
  3. #243VogenxVOGX$243.5M
  4. #244Akebia TherapeuticsAKBA$243.4M
  5. #245Q32 BioQTTB$241.4M

What if Vogenx were worth as much as…

Open the what-if tool →

Gold $28.8T

$1,938,019

Per share 118,244× higher

Bitcoin $1.67T

$112,436.08

Per share 6,860× higher

Nvidia $5.77T

$388,128.59

Per share 23,681× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Vogenx are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.